Biochemical and histological studies on H2-receptor antagonist ranitidine-induced hepatotoxicity in rats

Indian Journal of Experimental Biology

Volumn 43, Issue 9, 2005, Pages 782-785

  Hemieda, Faried A E ^a   Abdel Hady, El Sayed K ^a   Elnga, Mostafa A Abou ^b  

^a Mansoura University   (Egypt)

^b AL AZHAR UNIVERSITY   (Egypt)

Author keywords

ACP; ALT; AST; Hepatotoxicity; Ranitidine; Rats; Serum

Indexed keywords

ACID PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; HISTAMINE H2 RECEPTOR ANTAGONIST; RANITIDINE;

ANIMAL; ARTICLE; BLOOD; DOSE RESPONSE; DRUG EFFECT; HUMAN; LIVER; MALE; METABOLISM; PATHOLOGY; RAT; TOXIC HEPATITIS;

ACID PHOSPHATASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPATITIS, TOXIC; HISTAMINE H2 ANTAGONISTS; HUMANS; LIVER; MALE; RANITIDINE; RATS;

ANIMALIA;

EID: 24644461025     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Zeldis J B, Friedman L S & Isselbacher K J, Ranitidine, A new H2-receptor antagonist, N Engl J Med, 309 (1983) 1368.
2. Mills J G, Koch K M, Webster C, Sirgo M A, Fitzgerald K & Wood J R, Safety of ranitidine in over a decade of use, Aliment Pharmacol Ther, 11 (1997) 129.
3. Barr G D & Piper D W, Possible ranitidine hepatitis, Med J Aust, 2 (1981) 421.
4. Black M, Scott W E & Kanter R, Possible ranitidine hepatotoxicity, Ann Intern Med, 101 (1984) 208.
5. Hiesse C, Cantarovich M, Santelli C, Francais P, Charpentier B, Fries D & Buffet C, Ranitidine hepatotoxicity in renal transplant patient, Lancet, 1 (1985) 1280.
6. Cherqui B, Desaint B, Legendre C & Levy V G, Fetal hepatitis in a female patient treated with ranitidine (letter), [French] Gastroenterologie Clinique et Biologique, 13 (1989) 952.
7. Souza Lima M A, Ranitidine and the liver, Ann Intern Med, 102 (1985) 273.
8. Ramrakhiani S, Brunt E M & Bacon B R, Possible cholestatic injury from ranitidine with a review of the literature, Am J Gastroenterol, 93 (1998) 822.
9. Bredfeldt J E & von Huene C, Ranitidine, acetaminophen, and hepatotoxicity, Ann Intern Med, 101 (1984) 719.
10. Fisher A A & Le Couteur D G, Nephrotoxicity and hepatotoxicity of histamine H2 receptor antagonists, Drug Saf, 24 (2001) 39.
11. Garcia Rodriguez L A, Wallander M A & Stricker B H, The risk of acute liver injury associated with cimetidine and other acid-suppressing anti-ulcer drugs, Br J Clin Pharmacol, 43 (1997) 183.
12. Kanashima R, Nagasue N & Sakato K, Ranitidine as an inhibitor of liver regeneration, Am J Surg, 149 (1985) 223.
13. Reitman S & Frankel S, A colorimetric method for determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases, Am J Clin Pathol, 28 (1957) 56.
14. Kind P R N & King E J, Estimation of plasma phosphatase by determination of hydrolysed phenol with amino-antipyrine, J Clin Pathol, 7 (1954) 322.
15. th edition, (Tata McGraw-Hill Publishing Company Ltd, New Delhi) 1979, 1121.
16. Weesner F M, General Zoological Microtechniques, (Scientific Book Agency, Calcutta, India) 1968.
17. Hakanson R, Persson P, Axelson J, Johnell O & Sundler F, Evidence that gastrin enhances 45Ca uptake into bone through release of a gastric hormone, Regul Pept, 28 (1990) 107.
18. Persson P, Gagnemo-Persson R, Orberg J, Chen D & Hakanson R, Effects of gastrin on calcium homeostasis in chickens, Endocrinology, 129 (1991) 1162.
19. Adachi Y, Shiota E, Matsumata T, Iso Y, Yoh R & Kitano S, Bone mineral density in patients taking H2-receptor antagonist, Calcif Tissue Int, 62 (1998) 283.
20. nd edition, [Lloyd-Luke (Medical books) Ltd, London] 1975, 349.
21. Bertaccini G & Coruzzi G, Histamine H2-receptor agonists and antagonists on pancreatic exocrine secretion of the dog, Agents Actions, 16 (1985) 211.
22. Varga G, Scarpignato C & Papp M, Inhibition of pancreatic secretory and trophic response to caerulein by the H2-receptor antagonist ranitidine in the rat, Digestion, 31 (1985) 177.
23. Mansi C, Mela G S, Sciaba L, Pasini D, Chiaramondia M & Celle G, Different effects of intraperitoneal or subcutaneous administration of H2-antagonists on pancreatic response to chronic administration of caerulein in rats, Digestion, 41 (1988) 129.
24. Tamura J, Sato N, Ezaki H, Miyamoto H, Oda S, Hirai K, Tokado H, Matsumoto M & Shirai T, Acute toxicity of ranitidine and its metabolite in mice, rats and rabbits, and subacute oral toxicity of ranitidine in rats, J Toxicol Sci, 8 Suppl 1 (1983) 1.
25. Leonard T B, Morgan D G & Dent J G, Ranitidine-acetaminophen interaction: Effect on acetaminophen-induced hepatotoxicity in Fischer 344 rats, Hepatology, 5 (1985) 480.
26. Takeuchi M, Kaga M, Kiguchi M, Iwata M, Yamaguchi M, Shimpo K & Tanabe T, Chronic toxicity study of ranitidine hydrochloride orally administered in rats, J Toxicol Sci, 8 Suppl 1 (1983) 25.
27. Roy V, Gupta U, Sachdev G & Bapna J S, Adverse drug reactions to ranitidine, famotidine and omeprazole with special reference to hepatic functions and lipid profile: A prospective study, Indian J Pharmacol, 29 (1997) 20.
28. McCarthy D M, Ranitidine or cimetidine, Ann Intern Med, 99 (1983) 551.
29. Boyd M R, Toxicity mediated by reactive metabolites of furans, Adv Exp Med Biol, 136B (1980) 856.
30. Jack D & Smith R N, Hepatitis associated with ranitidine, JAMA, 252 (1984) 3253 (letter).
31. Abou Elnga M A, Hemieda F A E & Abdel-Hady E K, Biochemical and histological studies on the kidney of rats treated with anti-ulcer ranitidine, Proc I C B S, 3 (2004) 745.
32. Luparini R L, Rotundo A, Mattace R & Marigliano V, Possibly ranitidine-induced autoimmune hepatitis, Ann Ital Med Int, 15 (2000) 214.